Anamorelin vs hGHRH(1-32)NH2
Head-to-head comparison of Anamorelin (Anamorelin hydrochloride (ONO-7643)) and hGHRH(1-32)NH2 (Human growth hormone-releasing factor (1-32) amide) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Anamorelin | hGHRH(1-32)NH2 |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| Full Name | Anamorelin hydrochloride (ONO-7643) | Human growth hormone-releasing factor (1-32) amide |
| Molecular Weight | N/A | N/A |
| Half-Life | about 9 hours | 5-15 minutes |
| Amino Acids | N/A | 32 |
| Typical Dose | 50 mg/day | 0.1-1 mcg/kg |
| Route | Oral | Subcutaneous/IV |
| Purity | ≥98% | ≥98% |
| Studies Count | 95 | 50 |
| Research Status | Clinical | Clinical Research |
Anamorelin Benefits
- ✓stimulates appetite
- ✓raises IGF-1
- ✓may support weight gain
- ✓oral dosing
hGHRH(1-32)NH2 Benefits
- ✓GH pulse induction
- ✓core-sequence testing
- ✓receptor signaling studies
- ✓protease-resistance comparisons
Anamorelin Dosing
50 mg orally once daily|often studied with food or per protocol|track weight, appetite, and glucose markers
hGHRH(1-32)NH2 Dosing
0.1-1 mcg/kg SC or IV bolus|acute GH-response testing with timed blood draws|pulsatile dosing in receptor studies
Anamorelin Side Effects
- ⚠hyperglycemia
- ⚠peripheral edema
- ⚠constipation or nausea
hGHRH(1-32)NH2 Side Effects
- ⚠headache
- ⚠flushing
- ⚠injection-site irritation
Research Overview
Anamorelin
Trials in cachexia populations showed increased appetite and modest gains in body weight and IGF-1. Regulatory progress has varied by region, but it remains a well-studied ghrelin agonist in the GH space.
hGHRH(1-32)NH2
Human GHRF(1-32)NH2 is used in basic and translational studies to evaluate how the active N-terminal region of GHRH drives pituitary hormone release. It helps define the lower bound of sequence length needed for meaningful biological activity.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.